Tamoxifen citrate is the active pharmaceutical form associated with Nolvadex. As a SERM, tamoxifen binds to estrogen receptors and produces different effects depending on the tissue involved.
Its primary clinical role is the hormonal management of certain breast cancers that depend on estrogen receptor signaling. Tamoxifen can also be prescribed for breast cancer risk reduction in appropriately selected patients.
The stated strength is 20mg. Because tamoxifen influences estrogen pathways throughout the body, therapy can affect menstrual or menopausal symptoms, bone health, clotting risk, and uterine tissue.
Reviews
There are no reviews yet.